image

The best stocks to buy since 1993

Latest issue now available

Volex

November 2025

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • VLX
  • Price:
  • 389p
Ahead of reporting on 12 November, Volex said Q1 growth accelerated into Q2 and H1 revenues will now exceed US$575m, with organic growth of at least 11%. The H1 margin is expected to be at the upper end of the company’s range of 9-10%. There was strong growth in the Electric Vehicles, Off-Highway and Data Centre segments, offset by subdued demand in Medical and lower organic growth in Consumer electricals due to strong comparatives. A small number of new programme launches have been temporarily deferred to FY27 as a result of relocating manufacturing footprint in the data centre and EV segments to tackle tariffs. Singer has upgraded by 4% to US$71m pretax profit for EPS of 36.4 cents. Keep on buy list. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe